AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34454458 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapist-delivered pain science education (PSE) integrated with an individualised walking, strengthening, and general education program
Number of subjects: 198
Study 34454458 — intervention group
Group type: COMPARATOR
Intervention: Individualised physiotherapist-led walking, strengthening, and OA/activity education program
Number of subjects: 198
Study 34559601 — intervention group
Group type: EXPERIMENTAL
Intervention: menthol
Number of subjects: 12
Study 34559601 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study 32819404 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertebral cancellous bone infiltration anaesthesia
Number of subjects: 112
Study 32819404 — intervention group
Group type: COMPARATOR
Intervention: Local anaesthesia alone
Number of subjects: 112
Study 35930062 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe disc degeneration (Pfirrmann score 4-5)
Number of subjects: 437
Study 35930062 — intervention group
Group type: EXPERIMENTAL
Intervention: Other preoperative MRI findings
Number of subjects: 437
Study 32228512 — intervention group
Group type: EXPERIMENTAL
Intervention: gemcitabine + nab-paclitaxel (1000 mg/m2 gemcitabine + 125 mg/m2 nab-paclitaxel)
Number of subjects: 125
Study 32228512 — intervention group
Group type: COMPARATOR
Intervention: gemcitabine alone (1000 mg/m2)
Number of subjects: 125
Study 35862454 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeting pairs of friends (pair targeting)
Number of subjects: 2491
Study 35862454 — intervention group
Group type: EXPERIMENTAL
Intervention: Friendship nomination targeting
Number of subjects: 2491
Study 35862454 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeting 20% of women at random
Number of subjects: 2491
Study 35862454 — intervention group
Group type: COMPARATOR
Intervention: No targeting
Number of subjects: 2491
Study 33404620 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning alerts for dispatcher recognition of OHCA
Number of subjects: 654
Study 33404620 — intervention group
Group type: COMPARATOR
Intervention: Standard protocols without machine learning assistance
Number of subjects: 654
Study 33404620 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning alerts
Number of subjects: 654
Study 33404620 — intervention group
Group type: COMPARATOR
Intervention: Standard protocols without alerts
Number of subjects: 654
Study 32976320 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual transient elastography (ViTE)
Number of subjects: 227
Study 32976320 — intervention group
Group type: COMPARATOR
Intervention: FibroScan (FS)
Number of subjects: 227
Study 35155865 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid avoidance protocol (tacrolimus/MMF/antithymocyte globulin [ATG] induction)
Number of subjects: 222
Study 35155865 — intervention group
Group type: COMPARATOR
Intervention: Steroid maintenance protocol (tacrolimus/MMF/prednisolone/basiliximab-induction)
Number of subjects: 222
Study 32535191 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning algorithm for automated grading of CD ulcers on capsule endoscopy images
Number of subjects: 49
Study 32535191 — intervention group
Group type: COMPARATOR
Intervention: Consensus reading by 3 capsule readers
Number of subjects: 49
Study 33394524 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-swabbing
Number of subjects: 190
Study 33394524 — intervention group
Group type: COMPARATOR
Intervention: Conventional swabbing
Number of subjects: 190
Study 36315143 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 86
Study 36315143 — intervention group
Group type: COMPARATOR
Intervention: Moderate to Vigorous Intensity Continuous Training (CR)
Number of subjects: 86
Study 33548689 — intervention group
Group type: EXPERIMENTAL
Intervention: Sobriety Treatment and Recovery Teams (START)
Number of subjects: 348
Study 33548689 — intervention group
Group type: COMPARATOR
Intervention: Usual child welfare services
Number of subjects: 348
Study 34807274 — intervention group
Group type: EXPERIMENTAL
Intervention: RIRS
Number of subjects: 121
Study 34807274 — intervention group
Group type: COMPARATOR
Intervention: PCNL
Number of subjects: 121
Study 34357477 — intervention group
Group type: EXPERIMENTAL
Intervention: Expressive writing intervention (three 15-min sessions)
Number of subjects: 78
Study 34357477 — intervention group
Group type: COMPARATOR
Intervention: Control group writing sessions (equivalent to expressive writing)
Number of subjects: 78
Study 33860035 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-dimensional balanced manipulation (TBM)
Number of subjects: 120
Study 33860035 — intervention group
Group type: COMPARATOR
Intervention: Traditional massage (Control)
Number of subjects: 120
Study 35803777 — intervention group
Group type: EXPERIMENTAL
Intervention: Alveogyl dressings in extraction sites changed every 48 hours until cessation of pain (Group 2)
Number of subjects: 55
Study 35803777 — intervention group
Group type: EXPERIMENTAL
Intervention: PBMT following mechanical curettage and Alveogyl dressing (Group 3)
Number of subjects: 55
Study 35803777 — intervention group
Group type: EXPERIMENTAL
Intervention: PBMT only (Group 4)
Number of subjects: 55
Study 35803777 — intervention group
Group type: COMPARATOR
Intervention: Mechanical curettage (Group 1)
Number of subjects: 55
Study 34391295 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry needling (DN) applied to the gastrocnemius muscle
Number of subjects: 60
Study 34391295 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry needling (DN) applied to the erector spinae muscle
Number of subjects: 60
Study 34391295 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry needling (DN) applied to the infraspinatus muscle
Number of subjects: 60
Study 32053696 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin
Number of subjects: 40
Study 32053696 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 32053696 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 40
Study 33577117 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (school environmental strategies targeting SSB availability, placement, promotion, pricing, and increased water availability)
Number of subjects: 862
Study 33577117 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual programmes)
Number of subjects: 862
Study 34236624 — intervention group
Group type: EXPERIMENTAL
Intervention: Amantadine
Number of subjects: 0
Study 34236624 — intervention group
Group type: EXPERIMENTAL
Intervention: Various therapies (pharmacologic, electromagnetic, mechanical, sensory, regenerative)
Number of subjects: 0
Study 34236624 — intervention group
Group type: EXPERIMENTAL
Intervention: Precision medicine approach
Number of subjects: 0
Study 36127075 — intervention group
Group type: EXPERIMENTAL
Intervention: TRE with behavioural economic interventions (financial incentives and text reminders)
Number of subjects: 114
Study 36127075 — intervention group
Group type: EXPERIMENTAL
Intervention: TRE alone
Number of subjects: 114
Study 36127075 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 114
Study 36127075 — intervention group
Group type: EXPERIMENTAL
Intervention: TRE with behavioural economic interventions
Number of subjects: 114
Study 33403790 — intervention group
Group type: EXPERIMENTAL
Intervention: Dermabrasion plus 5-fluorouracil
Number of subjects: 36
Study 33403790 — intervention group
Group type: COMPARATOR
Intervention: Suction blister
Number of subjects: 36
Study 35057647 — intervention group
Group type: EXPERIMENTAL
Intervention: Ebola vaccine
Number of subjects: 0
Study 35057647 — intervention group
Group type: EXPERIMENTAL
Intervention: Mathematical modeling
Number of subjects: 0
Study 34207701 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component intervention program (exercise with cognitive training) for 12 weeks
Number of subjects: 0
Study 34207701 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component intervention program
Number of subjects: 0
Study 34207701 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 33375123 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored activity pacing intervention
Number of subjects: 21
Study 33375123 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 21
Study 35347164 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole grain rye/rye bran (485 g daily for 6 weeks)
Number of subjects: 17
Study 35347164 — intervention group
Group type: COMPARATOR
Intervention: Refined wheat (fiber supplemented, 485 g daily for 6 weeks)
Number of subjects: 17
Study 35347164 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole grain rye/rye bran
Number of subjects: 17
Study 33787563 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative counseling via phone call
Number of subjects: 120
Study 33787563 — intervention group
Group type: COMPARATOR
Intervention: Preoperative counseling via office visit
Number of subjects: 120
Study 33787563 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative counseling via phone call and office visit
Number of subjects: 120
Study 32943085 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-led, fibromyalgia-orientated exercise program
Number of subjects: 0
Study 32943085 — intervention group
Group type: COMPARATOR
Intervention: General exercise program (control)
Number of subjects: 0
Study 35969401 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist-supported internet-delivered ERP for tics (111 participants)
Number of subjects: 221
Study 35969401 — intervention group
Group type: COMPARATOR
Intervention: Therapist-supported internet-delivered education for tics (110 participants)
Number of subjects: 221
Study 33175253 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunologically active saliva substitute (IASS)
Number of subjects: 94
Study 33175253 — intervention group
Group type: COMPARATOR
Intervention: Non-immunologically active mouthwash (placebo)
Number of subjects: 94
Study 34530482 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral apixaban
Number of subjects: 1073
Study 34530482 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous dalteparin
Number of subjects: 1073
Study 33453190 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced Exercise (FE)
Number of subjects: 100
Study 33453190 — intervention group
Group type: EXPERIMENTAL
Intervention: Voluntary Exercise (VE)
Number of subjects: 100
Study 33453190 — intervention group
Group type: COMPARATOR
Intervention: No Exercise Control
Number of subjects: 100
Study 35883701 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (acute neuroendocrine challenge)
Number of subjects: 0
Study 35883701 — intervention group
Group type: COMPARATOR
Intervention: Placebo (acute neuroendocrine challenge)
Number of subjects: 0
Study 33607357 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (50 mg/day for 8 weeks)
Number of subjects: 51
Study 32712822 — intervention group
Group type: EXPERIMENTAL
Intervention: Locking Block Modified Krackow (LBMK)
Number of subjects: 30
Study 32712822 — intervention group
Group type: COMPARATOR
Intervention: Kessler
Number of subjects: 30
Study 32712822 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous Achilles Repair System (PARS)
Number of subjects: 30
Study 36378307 — intervention group
Group type: EXPERIMENTAL
Intervention: Single wound infiltration with bupivacaine and adrenaline
Number of subjects: 288
Study 36378307 — intervention group
Group type: COMPARATOR
Intervention: No single wound infiltration
Number of subjects: 288
Study 32990605 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral ecoimmunonutrition
Number of subjects: 60
Study 32990605 — intervention group
Group type: COMPARATOR
Intervention: Enteral nutrition
Number of subjects: 60
Study 33587510 — intervention group
Group type: EXPERIMENTAL
Intervention: VRC01 10 mg/kg
Number of subjects: 1924
Study 33587510 — intervention group
Group type: EXPERIMENTAL
Intervention: VRC01 30 mg/kg
Number of subjects: 1924
Study 33587510 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1924
Study 32061185 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted tango intervention (20 sessions of 90-min classes over 12 weeks)
Number of subjects: 62
Study 32061185 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted tango intervention
Number of subjects: 62
Study 35079243 — intervention group
Group type: EXPERIMENTAL
Intervention: Teledentistry diagnoses
Number of subjects: 70
Study 35079243 — intervention group
Group type: EXPERIMENTAL
Intervention: Teledentistry
Number of subjects: 70
Study 35079243 — intervention group
Group type: COMPARATOR
Intervention: Control group (traditional dental visits)
Number of subjects: 70
Study 32978188 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 120
Study 32978188 — intervention group
Group type: EXPERIMENTAL
Intervention: Sham Acupuncture (SA)
Number of subjects: 120
Study 32978188 — intervention group
Group type: COMPARATOR
Intervention: Waitlist Control
Number of subjects: 120
Study 33395586 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosa damascene essence 40% in distilled water inhalation for three consecutive nights from 22:00 to 06:00
Number of subjects: 60
Study 33395586 — intervention group
Group type: COMPARATOR
Intervention: Distilled water inhalation as placebo for three consecutive nights from 22:00 to 06:00
Number of subjects: 60
Study 35606864 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosa canina L. syrup + methylphenidate (MP)
Number of subjects: 90
Study 35606864 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyherbal formulation (PHF) syrup + methylphenidate (MP)
Number of subjects: 90
Study 35606864 — intervention group
Group type: COMPARATOR
Intervention: Placebo + methylphenidate (MP)
Number of subjects: 90
Study 34921679 — intervention group
Group type: EXPERIMENTAL
Intervention: Test cream containing ceramides, triglycerides, and cholesterol in a multivesicular emulsion
Number of subjects: 34
Study 34921679 — intervention group
Group type: EXPERIMENTAL
Intervention: Test cream
Number of subjects: 34
Study 34921679 — intervention group
Group type: COMPARATOR
Intervention: Reference emollient cream
Number of subjects: 34
Study 32731878 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial neural networks (ANN) model for early prediction of outcome
Number of subjects: 932
Study 32731878 — intervention group
Group type: EXPERIMENTAL
Intervention: Simplified ANN model using three variables (age, time to ROSC, first monitored rhythm)
Number of subjects: 932
Study 32731878 — intervention group
Group type: COMPARATOR
Intervention: Targeted temperature management (TTM) at 33°C or 36°C
Number of subjects: 932
Study 35022320 — intervention group
Group type: EXPERIMENTAL
Intervention: HCQ 600 mg po bid with D+T (dabrafenib 150 mg bid and trametinib 2 mg qd)
Number of subjects: 34
Study 35022320 — intervention group
Group type: EXPERIMENTAL
Intervention: HCQ+D+T in patients with elevated LDH (n=16)
Number of subjects: 34
Study 33045853 — intervention group
Group type: EXPERIMENTAL
Intervention: Epigallocatechin gallate (EGCG)
Number of subjects: 0
Study 33064385 — intervention group
Group type: EXPERIMENTAL
Intervention: D group (drain placement)
Number of subjects: 400
Study 33064385 — intervention group
Group type: COMPARATOR
Intervention: ND group (no drain placement)
Number of subjects: 400
Study 33357482 — intervention group
Group type: EXPERIMENTAL
Intervention: RVd
Number of subjects: 100
Study 33357482 — intervention group
Group type: COMPARATOR
Intervention: RVd-elotuzumab
Number of subjects: 100
Study 32860991 — intervention group
Group type: EXPERIMENTAL
Intervention: Sprifermin
Number of subjects: 0
Study 32860991 — intervention group
Group type: EXPERIMENTAL
Intervention: Sprifermin (highest dose)
Number of subjects: 0
Study 32860991 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 616484845 — intervention group
Group type: EXPERIMENTAL
Intervention: Giant exercising board game intervention
Number of subjects: 21
Study 616484845 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 21
Study 36056419 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab (5 mg/kg body weight) in addition to the standard of care
Number of subjects: 0
Study 36056419 — intervention group
Group type: COMPARATOR
Intervention: Standard of care alone
Number of subjects: 0
Study 33871742 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive implementation support (toolkits, clinical training, implementation facilitation, data-based feedback)
Number of subjects: 39
Study 33871742 — intervention group
Group type: COMPARATOR
Intervention: Control condition (manual only)
Number of subjects: 39
Study 33871742 — intervention group
Group type: EXPERIMENTAL
Intervention: Illness management and recovery
Number of subjects: 39
Study 33871742 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical health care
Number of subjects: 39
Study 33871742 — intervention group
Group type: EXPERIMENTAL
Intervention: Antipsychotic medication management
Number of subjects: 39
Study 33871742 — intervention group
Group type: EXPERIMENTAL
Intervention: Family psychoeducation
Number of subjects: 39
Study 35795633 — intervention group
Group type: EXPERIMENTAL
Intervention: Treat-and-Extend (T&E) regimen
Number of subjects: 141
Study 35795633 — intervention group
Group type: COMPARATOR
Intervention: Pro Re Nata (PRN) regimen
Number of subjects: 141
Study 33401241 — intervention group
Group type: COMPARATOR
Intervention: Repeated-sprint running (6 × 40 m)
Number of subjects: 12
Study 33401241 — intervention group
Group type: COMPARATOR
Intervention: Easy exercise (4 × 12 fast half squats, 6 speed ladder drills, and 20-m sprints)
Number of subjects: 12
Study 33401241 — intervention group
Group type: EXPERIMENTAL
Intervention: Control (no exercise)
Number of subjects: 12
Study 33468068 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac Peri‐Operative Transfusion Trigger Score (cPOTTS) group
Number of subjects: 500
Study 33468068 — intervention group
Group type: COMPARATOR
Intervention: Conventional evaluation of the need for transfusion (conventional group)
Number of subjects: 500
Study 35248785 — intervention group
Group type: COMPARATOR
Intervention: Bilateral dual tDCS (bi-tDCS)
Number of subjects: 24
Study 35248785 — intervention group
Group type: COMPARATOR
Intervention: Unilateral anodal tDCS (ua-tDCS)
Number of subjects: 24
Study 35248785 — intervention group
Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 24
Study 33337926 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation (laser)
Number of subjects: 32
Study 33337926 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 32845328 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Choices intervention in home setting
Number of subjects: 183
Study 32845328 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Choices intervention in clinic setting
Number of subjects: 183
Study 35775704 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional photodynamic therapy (c‐PDT)
Number of subjects: 50
Study 35775704 — intervention group
Group type: EXPERIMENTAL
Intervention: Daylight photodynamic therapy (dl‐PDT)
Number of subjects: 50
Study 35775704 — intervention group
Group type: COMPARATOR
Intervention: Both treatments
Number of subjects: 50
Study 32134326 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention
Number of subjects: 5109
Study 32134326 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate fitness (tertile 2)
Number of subjects: 5109
Study 32134326 — intervention group
Group type: EXPERIMENTAL
Intervention: High fitness (tertile 3)
Number of subjects: 5109
Study 32134326 — intervention group
Group type: EXPERIMENTAL
Intervention: Improvements in cardiorespiratory fitness (CRF)
Number of subjects: 5109
Study 32134326 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss
Number of subjects: 5109
Study 32134326 — intervention group
Group type: COMPARATOR
Intervention: Diabetes support and education (control)
Number of subjects: 5109
Study 37702629 — intervention group
Group type: EXPERIMENTAL
Intervention: Lazertinib
Number of subjects: 258
Study 37702629 — intervention group
Group type: COMPARATOR
Intervention: Gefitinib
Number of subjects: 258
Study 34479508 — intervention group
Group type: EXPERIMENTAL
Intervention: Reconsolidation Therapy (RT)
Number of subjects: 46
Study 34479508 — intervention group
Group type: COMPARATOR
Intervention: Paroxetine
Number of subjects: 46
Study 32925713 — intervention group
Group type: EXPERIMENTAL
Intervention: Yangyin Shuxin Decoction combined with standard treatment
Number of subjects: 64
Study 32925713 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 64
Study 35452347 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-rigid backpack type thoracolumbar orthosis (TLO)
Number of subjects: 48
Study 35452347 — intervention group
Group type: COMPARATOR
Intervention: Control group (no external support or exercise)
Number of subjects: 48
Study 33413555 — intervention group
Group type: EXPERIMENTAL
Intervention: C‐Mill training (10 sessions, 1 hour each, twice per week for 5 weeks)
Number of subjects: 36
Study 33413555 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 36
Study 32445690 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline plus Celecoxib
Number of subjects: 266
Study 32445690 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline plus Placebo
Number of subjects: 266
Study 32445690 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib plus Placebo
Number of subjects: 266
Study 32445690 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus Placebo
Number of subjects: 266
Study 34396891 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined plyometric and balance exercises (PLYO-BAL group; n=19)
Number of subjects: 57
Study 34396891 — intervention group
Group type: COMPARATOR
Intervention: Plyometric exercises (PLYO group; n=19)
Number of subjects: 57
Study 34396891 — intervention group
Group type: COMPARATOR
Intervention: Balance exercises (BAL group; n=19)
Number of subjects: 57
Study 34610049 — intervention group
Group type: EXPERIMENTAL
Intervention: Screened for AF using a continuous-recording ECG patch worn for two weeks and 2 occasions, 3 months apart.
Number of subjects: 5089
Study 34610049 — intervention group
Group type: COMPARATOR
Intervention: Observational controls (no screening).
Number of subjects: 5089
Study 32093339 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength exercise with 25-30% caloric restriction diet
Number of subjects: 162
Study 32093339 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance exercise with 25-30% caloric restriction diet
Number of subjects: 162